BUDIGALIMAB

UNII:	6VDO4TY3OO
Formula:
Preferred Substance Name:	BUDIGALIMAB

2098225-93-3
ABBV181
ABBV-181
ANTI-PD1 MONOCLONAL ANTIBODY ABBV-181
BUDIGALIMAB [INN]
BUDIGALIMAB [USAN]
BUDIGALIMAB [WHO-DD]
IMMUNOGLOBULIN G1, ANTI-(HUMAN PROGRAMMED CELL DEATH PROTEIN 1), (HUMAN-MUS MUSCULUS MONOCLONAL PR-1648817 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL PR-1648817 .KAPPA.-CHAIN, DIMER
IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENS PDCD1(PROGRAMMED CELL DEATH 1, PD-1, PD1, CD279)), MONOCLONAL ANTIBODYGAMMA1 HEAVY CHAIN (1-448) (VH (HOMO SAPIENS IGHV1-46*01(76.5%)-(IGHD)-IGHJ6*03 (90.9%)) (8.8.11) (1-118)-HOMOSAPIENS IGHG1*03V, G1M3>G1M17, NG1M1 (CH1 R120>K(215) (119-216), HINGE (217-231), CH2 L1.3>A (235), L1.2>A (236) (232-341), CH3 E12 (357), M14 (359) (342-446), CHS(447-448)) (119-448)), (221-219')-DISULFIDE WITH KAPPA LIGHT CHAIN(1'-219') (V-KAPPA (MUS MUSCULUS IGKV1-117*01(89.0%)/HOMO SAPIENS IGKV2-28*01 OR IGKV2-29*02 (85.0%)-HOMO SAPIENS IGKJ2*01 (100%)) (11.3.9) (1'-112')-HOMO SAPIENS IGKC*01, KM3 A45.1 (158), V101 (196) (113'-219'))DIMER (227-227'':230-230'')-BISDISULFIDE IMMUNOMODULATOR, ANTINEOPLASTIC
PR-1648817

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

BUDIGALIMAB

Synonyms and Mappings

Resources